Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_assertion type Assertion NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_head.
- NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_assertion description "[TERT promoter C228T and C250T mutations occur in various malignancies including bladder cancer (BC) and may serve as urinary tumor markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_provenance.
- NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_assertion evidence source_evidence_literature NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_provenance.
- NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_assertion SIO_000772 25474136 NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_provenance.
- NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_assertion wasDerivedFrom befree-2016 NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_provenance.
- NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_assertion wasGeneratedBy ECO_0000203 NP1244771.RAHfc_5gIGBQACeGbVLOmRW2OBGWD2XUx3yXiYZzkLmvY130_provenance.